ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Zealand Pharma AS

Zealand Pharma AS (22Z)

38.11
-0.11
(-0.29%)
終了 6月28日 5:00AM

Zealand Pharma AS (22Z) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
38.11
( -0.29% )
買値
37.92
売値
38.29
出来高
1,376
36.77 日の範囲 38.42
30.50 52 週間の範囲 74.26
時価総額
前日終値
38.22
始値
37.75
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
479,505 €
発行済株式数
70,239,093
配当利回り
PER
3.14
1 株当たり利益 (EPS)
89.42
歳入
9.24B
純利益
6.4B

Zealand Pharma AS について

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with ... Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon for treating congenital hyperinsulinism. In addition, the company developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Søborg, Denmark
設立
1997
Zealand Pharma AS is listed in the Healthcare sector of the Tradegate (DE) with ticker 22Z. The last closing price for Zealand Pharma AS was 38.22 €. Over the last year, Zealand Pharma AS shares have traded in a share price range of 30.50 € to 74.26 €.

Zealand Pharma AS currently has 70,239,093 shares in issue. The market capitalisation of Zealand Pharma AS is 2.68 € billion. Zealand Pharma AS has a price to earnings ratio (PE ratio) of 3.14.

22Z 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.511.3563829787237.639.7836.77176037.89635906DE
4-4.799999-11.186201612442.90999945.0231.97589436.67055146DE
12-2.28-5.6449616241640.3949.3331.97322338.51697833DE
26-26.65-41.151945645564.7666.1230.5302741.34184087DE
52-9.7-20.288642543447.8174.2630.5251648.36744862DE
1563.5710.335842501434.54132.530.5220673.09088909DE
2603.5710.335842501434.54132.530.5220673.09088909DE

22Z - Frequently Asked Questions (FAQ)

What is the current Zealand Pharma AS share price?
The current share price of Zealand Pharma AS is 38.11 €
How many Zealand Pharma AS shares are in issue?
Zealand Pharma AS has 70,239,093 shares in issue
What is the market cap of Zealand Pharma AS?
The market capitalisation of Zealand Pharma AS is EUR 2.68B
What is the 1 year trading range for Zealand Pharma AS share price?
Zealand Pharma AS has traded in the range of 30.50 € to 74.26 € during the past year
What is the PE ratio of Zealand Pharma AS?
The price to earnings ratio of Zealand Pharma AS is 3.14
What is the cash to sales ratio of Zealand Pharma AS?
The cash to sales ratio of Zealand Pharma AS is 2.13
What is the registered address of Zealand Pharma AS?
The registered address for Zealand Pharma AS is Sydmarken 11, Søborg, Capital Region of Denmark, 2860
What is the Zealand Pharma AS website address?
The website address for Zealand Pharma AS is www.zealandpharma.com
Which industry sector does Zealand Pharma AS operate in?
Zealand Pharma AS operates in the Biotechnology & Life Sciences sector

22Z 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード